Hyperlipoproteinemia Type 4 Overview

Save information for later
Sign Up

Learn About Hyperlipoproteinemia Type 4

What is the definition of Hyperlipoproteinemia Type 4?
Hyperlipoproteinemia Type IV, also known as carbohydrate-inducible hyperlipemia, is a condition in which an individual has high levels of very low-density lipoprotein (LDL) cholesterol and triglycerides (types of fat) in their blood. High levels of very low-density lipoprotein cholesterol and triglycerides can cause atherosclerosis, or the build-up of plaques of fatty cholesterol in the artery walls, which can lead to heart disease or stroke. Hyperlipoproteinemia Type IV is believed to occur in individuals who have a genetic predisposition for the disease and from consuming carbohydrates and alcohol.
What are the symptoms of Hyperlipoproteinemia Type 4?
Hyperlipoproteinemia may not cause any symptoms or may cause hypertriglyceridemic waist, which is an elevated waist circumference (>90 cm in men or >85 cm in women).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hyperlipoproteinemia Type 4?
Treatment for hyperlipoproteinemia Type IV includes the use of metformin, a medication that lowers blood glucose (sugar); atorvastatin, a drug that lowers blood cholesterol levels; and chenodeoxycholic acid, a bile acid that lowers the production of cholesterol in the liver and its absorption in the small intestine.
Who are the top Hyperlipoproteinemia Type 4 Local Doctors?
Distinguished in Hyperlipoproteinemia Type 4
Dr. Anthony R. Lanier
Family Medicine | Internal Medicine
Distinguished in Hyperlipoproteinemia Type 4
Dr. Anthony R. Lanier
Family Medicine | Internal Medicine
1150 Niles Cortland Rd, 
Niles, OH 
 (41.6 mi)
330-652-1759
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anthony Lanier is a Family Medicine specialist and an Internal Medicine provider in Niles, Ohio. Dr. Lanier and is rated as a Distinguished provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), Familial Hypercholesterolemia, Hyperlipoproteinemia Type 4, and Defective Apolipoprotein B-100. Dr. Lanier is currently accepting new patients.

Experienced in Hyperlipoproteinemia Type 4
Dr. Matthew M. Mark
Family Medicine
Experienced in Hyperlipoproteinemia Type 4
Dr. Matthew M. Mark
Family Medicine

University Primary Care Practices Inc

88 Ctr Rd, Suite 250a, 
Bedford, OH 
 (80.3 mi)
440-735-2804
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Mark is a Family Medicine provider in Bedford, Ohio. Dr. Mark and is rated as an Experienced provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Familial Hypercholesterolemia. Dr. Mark is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Hyperlipoproteinemia Type 4
Dr. Barry A. Effron
Cardiology
Experienced in Hyperlipoproteinemia Type 4
Dr. Barry A. Effron
Cardiology

University Hospitals Medical Group Inc

3999 Richmond Rd, 
Beachwood, OH 
 (81.1 mi)
216-593-5500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Barry Effron is a Cardiologist in Beachwood, Ohio. Dr. Effron and is rated as an Experienced provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, and Atrial Fibrillation. Dr. Effron is currently accepting new patients.

View All Doctors
What are the latest Hyperlipoproteinemia Type 4 Clinical Trials?
A Multi-center, Open Label, Multi-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Tolerance of Gene Therapy Drug GC304 in the Treatment of Primary Hypertriglyceridemia Patients With History of Acute Pancreatitis
A Multi-center, Open Label, Multi-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Tolerance of Gene Therapy Drug GC304 in the Treatment of Primary Hypertriglyceridemia Patients With History of Acute Pancreatitis
Enrollment Status: Recruiting
Publish Date: September 25, 2024
Intervention Type: Genetic
Study Phase: Phase 1

Summary: The study will evaluate safety and tolerance of intravenous delivery of GC304 gene therapy drug as a treatment of primary hypertriglyceridemic patients with previous onset of acute pancreatitis.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials